Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Chemotherapy Effect
Interventions: DRUG: Capecitabine
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University